Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20582981 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: gemtuzumab ozogamicin;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Procedure: allogeneic bone marrow transplantation

Indicates status has not been verified in more than two years